AbbVie reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AbbVie using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $3.00 | $2.92 | 2.74 % |
Jun 2024 | 2024-07-25 | $2.65 | $2.57 | 3.11 % |
Mar 2024 | 2024-04-26 | $2.31 | $2.23 | 3.59 % |
Dec 2023 | 2024-02-02 | $2.79 | $2.77 | 0.72 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $14.46B | $14.28B | 1.26 % |
Jun 2024 | 2024-07-25 | $14.46B | $14.03B | 3.08 % |
Mar 2024 | 2024-04-26 | $12.31B | $11.92B | 3.27 % |
Dec 2023 | 2024-02-02 | $14.30B | $14.02B | 2.00 % |
AbbVie (ABBV) is scheduled to report earnings on January 31, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $3.00, which beat the estimate of $2.92.
The Actual Revenue was $14.5B, which beat the estimate of $14.3B.
Browse earnings estimates, EPS, and revenue on all stocks.